HOME >> BIOLOGY >> NEWS
Robert S. Langer to present the 2001 Ullyot Public Affairs Lecture

Biomaterials and how they will change our lives

Philadelphia--Robert S. Langer, Kenneth J. Germeshausen Professor of Chemical and Biomedical Engineering at the Massachusetts Institute of Technology, has been chosen to deliver the 2001 Ullyot Public Affairs Lecture with a presentation titled "Biomaterials and How They Will Change Our Lives." The lecture, scheduled to take place at the Chemical Heritage Foundation on Thursday, 20 September 2001, will discuss advances in drug delivery that have revolutionized the medical industry. Since joining the MIT faculty in 1977, Langer has specialized in controlled drug delivery and tissue engineering. His discoveries are at the heart of today's multi-billion dollar controlled drug delivery industry and have provided a framework for the emerging technology of tissue engineering. Much of Langer's research has been in biomedical applications of polymers, and his groundbreaking research dispelled the belief that only some sizes of molecules could be delivered slowly.

Langer's later research has led to the development of a number of novel biodegradable polymers with medical applications. One of these resulted in a drug delivery system for the treatment of brain cancer (developed with Dr. Henry Brem of Johns Hopkins University Medical School)-the first FDA-approved treatment for brain cancer in 20 years and the first polymer-based treatment to deliver chemotherapy directly to a tumor site. This treatment has extended the lives of numerous patients and has far fewer side effects than conventional chemotherapy.

Langer has received over eighty major awards. In 1996, he became the only engineer to receive the Gairdner Foundation International Award; fifty-four recipients of this award have subsequently received a Nobel Prize. He received the $500,000 Lemelson-MIT prize, the world's largest prize for invention, in 1998 for being, "one of history's most prolific inventors in medicine," and
'"/>

Contact: Scott P. Lockledge
scottl@chemheritage.org
215-925-2222
Chemical Heritage Foundation
21-Aug-2001


Page: 1 2

Related biology news :

1. Dr. Robert Langer, distinguished leader in the field of biomedical engineering, to lecture at NIH
2. UC Riversides professor Robert Graham elected Fellow of the Soil Science Society of America
3. Robert Horvitz, pioneer in cell death, to be awarded international genetics prize
4. Dr. Robert C. Gallo to Collaborate with Visiting Israeli Scientist on Promising HIV Vaccine Research at Marylands Institute of Human Virology
5. DFG presents the 2004 MAK and BAT value lists
6. Presidential Recognition Awards presented at the 2004 AIUM Annual Convention
7. National study shows dog and cat allergens are universally present in U.S. homes
8. VIB presents its annual results at BIO2004 in San Francisco
9. White House lauds Physiological Society for mentoring underrepresented minorities in biomedicine
10. AACR awards scholarships to minority and underrepresented scientists
11. Steroid-coated DNA represents new approach to gene delivery

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Robert Langer present the Ullyot Public Affairs Lecture

(Date:10/14/2014)... the planet,s leading questions is how to produce enough ... climate. The Food and Agriculture Organization of the United ... the next 40 years to feed a growing global ... necessary rise in food production. Plants—grains, cereals, fruits, ... livestock. Current research must tap into our knowledge ...
(Date:10/14/2014)... CA – October 14, 2014 – Scientists from The ... from the National Institutes of Health (NIH) to lead ... virus-induced hemorrhagic fever disease in Africa. The study aims ... why some patients die, while others survive the inflection. ... understand the basic mechanism of how Lassa fever virus ...
(Date:10/14/2014)... likely takes between 10 and 20 years to ... window" of intervention if detected early, which may ... say Australian clinical researchers. , Dr Jeremy ... Institute of Medical Research, analysed medical histories and ... pancreatic cancer patients, operated on between 1994 and ...
Breaking Biology News(10 mins):Building a bridge from basic botany to applied agriculture 2Building a bridge from basic botany to applied agriculture 3Scripps Research Institute team receives $6.6 million to investigate deadly Lassa virus 2Early detection window when pancreatic cancer is in the family 2
(Date:10/19/2014)... The Asia-Pacific Speech Analytics market report defines and ... and forecast of revenue. This market is estimated to ... by 2019, at a Compound Annual Growth Rate (CAGR) ... the TOC of the Asia-Pacific Speech Analytics market report ... It also provides a glimpse of the segmentation in ...
(Date:10/18/2014)... (PRWEB) October 19, 2014 The ... (Short Acting, Intermediate Acting, Premixed), Modern Human Insulin ... Apidra, Levemir, NovoRapid, Novomix, Tresiba, Others) - Forecast ... major drivers, restraints, challenges, opportunities, current market trends, ... along with the estimates and forecasts of the ...
(Date:10/18/2014)... (PRWEB) October 18, 2014 The Asia-Pacific ... and segments the concerned market in Asia-Pacific with analysis ... $72.6 million in 2013, and is expected to reach ... from 2013 to 2018. , Browse through the TOC ... an idea of the in-depth analysis provided. This also ...
(Date:10/18/2014)... The “Global Diagnostic Electrocardiograph (ECG) ... End-user (Hospitals, Home/Ambulatory, Research Center, Physician Office, Nursing ... Forecast to 2020” provides a detailed overview of ... trends, and strategies impacting the global diagnostic ECG ... the revenue and share analysis. , The global ...
Breaking Biology Technology:The Asia-Pacific Speech Analytics market is estimated to reach $208 million by 2019 - New Report by MicroMarket Monitor 2The Asia-Pacific Speech Analytics market is estimated to reach $208 million by 2019 - New Report by MicroMarket Monitor 3The Asia-Pacific Speech Analytics market is estimated to reach $208 million by 2019 - New Report by MicroMarket Monitor 4Medical Human Insulin Market Is Expected to Reach $42 billion by 2019 - New Research Report by MarketsandMarkets 2Medical Human Insulin Market Is Expected to Reach $42 billion by 2019 - New Research Report by MarketsandMarkets 3Medical Human Insulin Market Is Expected to Reach $42 billion by 2019 - New Research Report by MarketsandMarkets 4Medical Human Insulin Market Is Expected to Reach $42 billion by 2019 - New Research Report by MarketsandMarkets 5The Asia-Pacific Liquid Crystal on Silicon (LCoS) display market is expected to reach $380.0 million by 2018 - New Report by MicroMarket Monitor 2The Asia-Pacific Liquid Crystal on Silicon (LCoS) display market is expected to reach $380.0 million by 2018 - New Report by MicroMarket Monitor 3The Electrocardiograph (ECG) Market Is Expected to Reach $5,435 Million By 2020 - New Research Report by MarketsandMarkets 2The Electrocardiograph (ECG) Market Is Expected to Reach $5,435 Million By 2020 - New Research Report by MarketsandMarkets 3The Electrocardiograph (ECG) Market Is Expected to Reach $5,435 Million By 2020 - New Research Report by MarketsandMarkets 4The Electrocardiograph (ECG) Market Is Expected to Reach $5,435 Million By 2020 - New Research Report by MarketsandMarkets 5
Cached News: